X0202 SCHEDULE 13G/A 0002050471 XXXXXXXX LIVE 2 Common Shares, no par value 09/30/2026 0001997296 Medicus Pharma Ltd. 58471K301 300 CONSHOHOCKEN STATE RD. SUITE 200 W. CONSHOHOCKEN PA 19428 Rule 13d-1(d) Melani Kenneth R. X1 3248741.00 0.00 3248741.00 0.00 3248741.00 N 3.6 IN Includes: (i) 409,411 common shares held by Dr. Kenneth Melani and (ii) 2,839,330 common shares held by Velocity Fund Partners, LP and entity controlled by Dr. Kenneth Melani. Dr. Kenneth Melani may be deemed the beneficial owner of securities held by Velocity Fund Partners, LP. Dr. Kenneth Melani disclaims beneficial ownership of such securities except to the extent of his direct ownership. VELOCITY FUND PARTNERS, LP DE 2839330.00 0.00 2839330.00 0.00 2839330.00 N 3.2 PN Medicus Pharma Ltd. 300 CONSHOHOCKEN STATE RD., SUITE 200, W. CONSHOHOCKEN, PENNSYLVANIA, 19428. This statement is being filed on behalf of each of the following persons (collectively, the "Reporting Persons"): (i) Dr. Kenneth Melani; and (ii) Velocity Fund Partners, LP The principal business address of each of the Reporting Persons is as follows: 1100 Stonegate Manor Cheswick, PA 15024 See Row (4) of each Reporting Person's cover page. Y Dr. Kenneth Melani directly owns 409,411 common shares of Medicus Pharma Ltd. (the "Company"). Velocity Fund Partners, LP an entity controlled by Dr. Kenneth Melani, directly owns 2,839,330 common shares. Dr. Kenneth Melani may be deemed the beneficial owner of the securities held by Velocity Fund Partners, LP. Dr. Kenneth Melani disclaims beneficial ownership of such securities except to the extent of this direct ownership. See Row (11) of each Reporting Person's cover page. The percentages used herein are calculated based upon an aggregate of 89,762,721common shares reported to be outstanding as of September 10, 2026, as reflected in the Report on Schedule 13D filed by the Company's Executive Chairman & CEO on September 14, 2026. See Row (5) of each Reporting Person's cover Page See Row (6) of each Reporting Person's cover Page See Row (7) of each Reporting Person's cover Page See Row (8) of each Reporting Person's cover Page N Y Y Y Y Y Y Exhibit 99.1: Joint Filing Agreement (previously filed as Exhibit 99.1 to the Schedule 13G filed on February 13, 2025, and incorporated herein by reference). Melani Kenneth R. /s/ Kenneth Melani 10/16/2026 VELOCITY FUND PARTNERS, LP /s/ Kenneth Melani 10/16/2026